Finance

Lists
6OP:FRA
Ose Immunotherapeutics SA
2,08 €
+0,77%
(+0,016) 1D
9 հոկ, 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 6OP...
Open
2,08 €
High
2,08 €
Low
2,08 €
Mkt. cap
50,10 մլն
Avg. vol.
47,00
Volume
0,00
52-wk high
6,95 €
52-wk low
2,03 €
EPS
-1,69 €
No. of employees
64
Open
2,08 €
High
2,08 €
Low
2,08 €
Mkt. cap
50,10 մլն
Avg. vol.
47,00
Volume
0,00
52-wk high
6,95 €
52-wk low
2,03 €
EPS
-1,69 €
No. of employees
64
News stories
From web sources and news partners
About Ose Immunotherapeutics SA
CEO-
Employees64
Founded17 նոյ, 2004 թ.
Headquarters-
Sector-
Websiteose-immuno.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2024 թ. սեպ
2024 թ. դեկ
Revenue
431,00 հզր
431,00 հզր
Cost of goods sold
-
-
Cost of revenue
-
-
Research and development expenses
8,28 մլն
8,28 մլն
Total research and development expenses
-
-
Selling, general, and admin expenses
1,08 մլն
1,08 մլն
Operating expense
10,22 մլն
10,22 մլն
Total operating expenses
10,22 մլն
10,22 մլն
Operating income
-9,79 մլն
-9,79 մլն
Other non operating income
-611,00 հզր
-611,00 հզր
EBT including unusual items
-10,44 մլն
-10,44 մլն
EBT excluding unusual items
-10,53 մլն
-10,53 մլն
Income tax expense
-576,50 հզր
-576,50 հզր
Effective tax rate
5,52%
5,52%
Other operating expenses
41,00 հզր
41,00 հզր
Net income
-9,86 մլն
-9,86 մլն
Net profit margin
-2 288,86%
-2 288,86%
Earnings per share
-
-
Interest and investment income
571,00 հզր
571,00 հզր
Interest expense
-707,50 հզր
-707,50 հզր
Net interest expenses
-136,50 հզր
-136,50 հզր
Depreciation and amortization charges
-
-
EBITDA
-9,74 մլն
-9,74 մլն
Gain or loss from assets sale
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps